Diagnostic and prognostic value of serum prostate specific antigen in prostate carcinoma. P.Grammaticos Free Text
Nuclear medicine procedures in lung cancer imaging. D.Boundas, N.Karatzas Free Text
Radio- and chemo-sensitization of human erythroleukemic K562 cells by the histone deacetylase inhibitor Trichostatin A. T.C. Karagiannis, A.J. Smith, A. El’ Osta Free Text
Radiation dose rate and urinary activity in patients with differentiated thyroid carcinoma treated with radioiodine-131; a survey in Iranian population S.Shahhosseini, D.Beiki, S.Dadashzadeh, M.Eftekhari, H.Tayebi, G.Moosazadeh Rashti Free Text
Isolation period prediction in patients with differentiated thyroid carcinoma treated after thyroidectomy by radioiodine-131. P.Markou, D.Chatzopoulos Free Text
Correlation of procollagen (I) with prostate specific antigen and bone scan for the diagnosis of bone metastases in patients with prostate carcinoma. A.Zissimopoulos, C.Stellos, G.Petrakis, N.Baziotis Free Text
Thyroglobulin increment after thyroid hormone withdrawal is a reliable indicator for the detection of significant remnants or metastases in patients with differentiated thyroid carcinoma. R.Zakavi, Z.Mousavi, N.R.Farid Free Text
Scintigraphic patterns in patients with subclinical hyperthyroidism. F.Canbaz, T.Basoglu, D.Kececi, O.Yapici, M.Alkurt Free Text
Semi-quantitative assessment of salivary gland function in patients with differentiated thyroid carcinoma after radioiodine-131 treatment. A.F.Esfahani, B.Fallahi, R.Olamaie, M.Eftekhari, D.Beiki, M.Saghari Free Text
A patient with MEN-IIA syndrome due to de novo mutation and papillary thyroid carcinoma; the role of 99mTc-depreotide in diagnosing metastases and brief review of the literature P.Valsamaki, S.Gerali, A.Arka, D.Kotsias, S.Lucchetti, K.Psarrakos, C.Zerva, A.Gotzamani-Psarrakou Free Text
Suspected thyroid stunning after 131I scanning in a patient with a diffuse goiter. J.W. van Isselt, P.C.Oldenburg-Ligtenberg, P.P.van Rijk Free Text
Cost analysis of twenty-nine nuclear medicine procedures. C.K.Kastanioti, G.Αlbouharali, A.Fotopoulos Free Text
The Hellenic Society of Nuclear Medicine was established on 1988 in Thessaloniki. The purpose of this society is the development of Nuclear Medicine as a specialty and the development of research, teaching and training in Nuclear Medicine.
